Insmed (INSM) Interest & Investment Income (2010 - 2026)
Insmed's (INSM) quarterly Interest & Investment Income came in at $12.0 million in Q1 2026, down 13.42% year-on-year from $13.9 million in Q1 2025, and down 20.98% quarter-over-quarter from $15.2 million in Q4 2025.
Insmed (INSM) Interest & Investment Income (2010 - 2026) Analysis & Trends
Insmed's Interest & Investment Income history runs 17 years deep, the most recent figure standing at $12.0 million for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 13.42% year-over-year to $12.0 million in Q1 2026; TTM through Mar 2026 was $58.8 million, a 0.62% increase from a year earlier, with the FY2025 full-year figure at $60.7 million, up 13.79% from the prior year.
- Interest & Investment Income retreated to $12.0 million in Q1 2026 per INSM's latest filing, from $15.2 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $18.3 million in Q3 2025 and bottomed at $137000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $10.6 million (2023), against an average of $10.5 million.
- Across the five-year window, Interest & Investment Income surged 13536.07% in 2022 and slipped 16.54% in 2024, its largest moves.
- Year by year, Interest & Investment Income stood at $8.3 million in 2022, then gained by 18.45% to $9.9 million in 2023, then surged by 75.14% to $17.3 million in 2024, then decreased by 11.71% to $15.2 million in 2025, then slipped by 20.98% to $12.0 million in 2026.
- Per Business Quant, the three latest INSM Interest & Investment Income figures stand at $12.0 million (Q1 2026), $15.2 million (Q4 2025), and $18.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Insmed | 22.60 Bn | 21.38 Bn | 258.54 Mn | 12.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.04 Mn |
| Dec 31, 2025 | 15.24 Mn |
| Sep 30, 2025 | 18.29 Mn |
| Jun 30, 2025 | 13.23 Mn |
| Mar 31, 2025 | 13.91 Mn |
| Dec 31, 2024 | 17.26 Mn |
| Sep 30, 2024 | 16.98 Mn |
| Jun 30, 2024 | 10.29 Mn |
| Mar 31, 2024 | 8.78 Mn |
| Dec 31, 2023 | 9.85 Mn |
| Sep 30, 2023 | 10.58 Mn |
| Jun 30, 2023 | 11.17 Mn |
| Mar 31, 2023 | 10.52 Mn |
| Dec 31, 2022 | 8.32 Mn |
| Sep 30, 2022 | 1.79 Mn |
| Jun 30, 2022 | 835,000.00 |
| Mar 31, 2022 | 137,000.00 |
| Dec 31, 2021 | 61,000.00 |
| Sep 30, 2021 | 46,000.00 |
| Jun 30, 2021 | 34,000.00 |